Argenx Se (ARGX) Divestments (2023 - 2025)
Argenx Se's (ARGX) quarterly Divestments came in at -$3.5 million in Q4 2025, down 50.09% YoY from -$7.1 million in Q4 2024, and up 6.59% on a QoQ basis from -$3.8 million in Q3 2025.
Argenx Se (ARGX) Divestments (2023 - 2025) Analysis & Trends
Argenx Se (ARGX) has 3 years of Divestments data on file, last reported at -$3.5 million in Q4 2025.
- Quarterly Divestments fell 50.09% year-over-year to -$3.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$12.4 million (down 62.09% YoY) and the FY2025 annual result came in at $12.4 million, up 62.09% from the prior year.
- Divestments rose to -$3.5 million in Q4 2025, from -$3.8 million in the prior quarter.
- In the past five years, Divestments ranged from a high of -$743000.0 in Q3 2023 to a low of -$3.8 million in Q3 2025.
- A 3-year average of -$2.3 million and a median of -$2.1 million in 2024 frame the typical range for Divestments.
- Annual changes were most pronounced in 2024 — Divestments slumped 166.62% — and 2025, when it declined 28.74%.
- Tracing ARGX's Divestments over 3 years: stood at -$1.8 million in 2023, then slumped by 31.43% to -$2.4 million in 2024, then slumped by 50.09% to -$3.5 million in 2025.
- The last three Divestments figures came in at -$3.5 million (Q4 2025), -$3.8 million (Q3 2025), and -$2.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 9.82 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -13.21 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.53 Mn |
| Sep 30, 2025 | -3.78 Mn |
| Jun 30, 2025 | -2.78 Mn |
| Mar 31, 2025 | -2.31 Mn |
| Dec 31, 2024 | -2.35 Mn |
| Sep 30, 2024 | -1.98 Mn |
| Jun 30, 2024 | -1.52 Mn |
| Mar 31, 2024 | -1.79 Mn |
| Dec 31, 2023 | -1.79 Mn |
| Sep 30, 2023 | -743,000.00 |